Safdarpour, S., Eidi, A., & Mortazavi, P
According to NICE guidance, Mounjaro is recommended for people with: BMI of at least 35 kg/m and at least one weight-related health condition, or BMI of at least 30 kg/m with type 2 diabetes NICE recommends Mounjaro be prescribed alongside a reduced-calorie diet and increased physical activity, with treatment reviewed after 12 months to assess effectiveness 6
Telehealth patients on compounded tirzepatide receive medication shipped directly to their home
What if I don't lose the expected amount of weight
In some situations, companies claim that federal approval from the FDA shields them from certain state law claims
A genome-wide analysis revealed that variation in HbA1C reduction with GLP-1 receptor agonist treatment was associated with a common genetic variation in GLP1R (rs6923761GA (Gly168Ser)) and a rare variant in ARRB1 (rs140226575GA (Thr370Met)) (58)